SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001193805-14-000561
Filing Date
2014-03-24
Accepted
2014-03-24 16:47:03
Documents
3
Effectiveness Date
2014-03-24

Document Format Files

Seq Description Document Type Size
1 e612053_f6pos-astellas.htm F-6 POS 138786
2 e612053_ex99-a.htm EX-99.(A) 72751
3 e612053_ex99-e.htm EX-99.(E) 11446
  Complete submission text file 0001193805-14-000561.txt   224359
Mailing Address 60 WALL STREET NEW YORK NY 10005
Business Address 60 WALL STREET NEW YORK NY 10005 212-250-9100
Astellas Pharma Inc (Subject) CIK: 0001446390 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: F-6 POS | Act: 33 | File No.: 333-153982 | Film No.: 14713612

Mailing Address 60 WALL STREET NEW YORK NY 10005
Business Address 60 WALL STREET NEW YORK NY 10005 212-319-7600
Deutsche Bank Trust Co Americas/ ADR Group (Filed by) CIK: 0001471515 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: F-6 POS